Tacalyx, a biotech oncology startup company focused on the discovery and development of Tumor Associated Carbohydrate Antigen (TACA) antibodies to treat cancer, has raised $7.7 million (€7 million) in seed funding to advance its discovery platform, progress obtained leads towards candidate […]